As Procter And Gamble Co (PG) Stock Value Declined, Girard Partners LTD Has Cut Its Stake by $336,240; Kopp Investment Advisors Maintains Holding in Horizon Pharma Plc (HZNP)

January 18, 2018 - By Evgen Dobrzhanskiy

Girard Partners Ltd decreased its stake in Procter And Gamble Co (PG) by 8.76% based on its latest 2017Q3 regulatory filing with the SEC. Girard Partners Ltd sold 3,736 shares as the company’s stock declined 5.32% while stock markets rallied. The institutional investor held 38,929 shares of the package goods and cosmetics company at the end of 2017Q3, valued at $3.54M, down from 42,665 at the end of the previous reported quarter. Girard Partners Ltd who had been investing in Procter And Gamble Co for a number of months, seems to be less bullish one the $228.78B market cap company. The stock decreased 0.37% or $0.33 during the last trading session, reaching $90.18. About 5.96M shares traded. The Procter & Gamble Company (NYSE:PG) has risen 7.54% since January 18, 2017 and is uptrending. It has underperformed by 9.16% the S&P500.

Kopp Investment Advisors Llc increased its stake in Horizon Pharma Plc (HZNP) by 403.79% based on its latest 2017Q3 regulatory filing with the SEC. Kopp Investment Advisors Llc bought 89,380 shares as the company’s stock declined 38.11% while stock markets rallied. The institutional investor held 111,515 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $1.41 million, up from 22,135 at the end of the previous reported quarter. Kopp Investment Advisors Llc who had been investing in Horizon Pharma Plc for a number of months, seems to be bullish on the $2.49B market cap company. The stock increased 1.47% or $0.22 during the last trading session, reaching $15.21. About 2.22M shares traded or 4.46% up from the average. Horizon Pharma Public Limited Company (NASDAQ:HZNP) has declined 28.13% since January 18, 2017 and is downtrending. It has underperformed by 44.83% the S&P500.

Kopp Investment Advisors Llc, which manages about $252.21 million and $109.12 million US Long portfolio, decreased its stake in Intersect Ent Inc. (NASDAQ:XENT) by 77,591 shares to 224,372 shares, valued at $6.99M in 2017Q3, according to the filing.

Among 13 analysts covering Horizon Pharma (NASDAQ:HZNP), 11 have Buy rating, 0 Sell and 2 Hold. Therefore 85% are positive. Horizon Pharma had 54 analyst reports since September 9, 2015 according to SRatingsIntel. The company was maintained on Thursday, November 30 by UBS. The stock has “Buy” rating by BMO Capital Markets on Monday, October 30. Mizuho maintained the stock with “Buy” rating in Tuesday, November 8 report. The rating was downgraded by Cowen & Co on Friday, September 16 to “Market Perform”. The firm has “Buy” rating given on Friday, July 14 by Piper Jaffray. The rating was maintained by Mizuho with “Buy” on Tuesday, November 10. Citigroup upgraded Horizon Pharma Public Limited Company (NASDAQ:HZNP) on Monday, November 28 to “Buy” rating. The firm has “Underweight” rating by Morgan Stanley given on Thursday, December 3. Mizuho maintained it with “Buy” rating and $22 target in Tuesday, February 28 report. BMO Capital Markets maintained Horizon Pharma Public Limited Company (NASDAQ:HZNP) on Monday, August 7 with “Buy” rating.

Investors sentiment increased to 1 in Q3 2017. Its up 0.08, from 0.92 in 2017Q2. It improved, as 33 investors sold HZNP shares while 50 reduced holdings. 28 funds opened positions while 55 raised stakes. 132.29 million shares or 1.03% more from 130.94 million shares in 2017Q2 were reported. Balasa Dinverno & Foltz Ltd Co, a Illinois-based fund reported 50,000 shares. Globeflex Capital Lp has invested 0.23% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Prelude Management Ltd Liability Company owns 0% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 1,700 shares. Markston Intl Limited Liability Company owns 0% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 150 shares. Tekla Capital Mngmt Limited Company has invested 0.07% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Stoneridge Invest Prtnrs Ltd Liability Corp has 0.03% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 14,946 shares. State Street holds 4.51 million shares. The Pennsylvania-based Pnc Finance Group has invested 0% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Moreover, Drw Securities Lc has 0.17% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 43,000 shares. Glenmede Tru Co Na has 0.22% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Renaissance Technology Limited Liability Corp reported 1.11M shares stake. Panagora Asset Incorporated accumulated 341,840 shares. Hutchin Hill Cap L P, New York-based fund reported 41,100 shares. Prudential Pcl owns 339,296 shares for 0.01% of their portfolio. Citigroup Incorporated holds 0.01% or 1.35 million shares in its portfolio.

Among 24 analysts covering Proctor & Gamble (NYSE:PG), 12 have Buy rating, 0 Sell and 12 Hold. Therefore 50% are positive. Proctor & Gamble had 74 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was maintained by Bank of America on Tuesday, September 19 with “Buy”. The rating was downgraded by Zacks on Tuesday, August 4 to “Hold”. The firm has “Buy” rating by B. Riley & Co given on Wednesday, October 26. The company was maintained on Thursday, August 4 by Citigroup. The firm has “Hold” rating given on Friday, June 30 by RBC Capital Markets. The stock has “Buy” rating by Jefferies on Thursday, July 27. Jefferies maintained the shares of PG in report on Monday, December 18 with “Buy” rating. The stock of The Procter & Gamble Company (NYSE:PG) has “Overweight” rating given on Thursday, October 29 by Barclays Capital. The stock of The Procter & Gamble Company (NYSE:PG) has “Buy” rating given on Wednesday, November 15 by Jefferies. The stock of The Procter & Gamble Company (NYSE:PG) has “Hold” rating given on Tuesday, September 5 by RBC Capital Markets.

Investors sentiment decreased to 0.82 in 2017 Q3. Its down 0.12, from 0.94 in 2017Q2. It dived, as 51 investors sold PG shares while 765 reduced holdings. 110 funds opened positions while 558 raised stakes. 1.50 billion shares or 1.10% more from 1.48 billion shares in 2017Q2 were reported. Hamel Associates holds 78,721 shares. Beck Mack And Oliver Llc holds 0.32% or 106,061 shares. Schroder Inv Mgmt Grp reported 3.37M shares stake. Moreover, Biondo Advsrs Limited Com has 0.07% invested in The Procter & Gamble Company (NYSE:PG) for 2,775 shares. Associated Banc holds 1.42% in The Procter & Gamble Company (NYSE:PG) or 283,238 shares. Halsey Associate Inc Ct owns 0.4% invested in The Procter & Gamble Company (NYSE:PG) for 22,567 shares. Cacti Asset Mgmt Limited Liability has 1.15% invested in The Procter & Gamble Company (NYSE:PG). Bowen Hanes holds 58,381 shares or 0.25% of its portfolio. Royal National Bank & Trust Of Scotland Group Public Ltd Company reported 2,977 shares stake. Mackenzie Fin owns 1.85M shares. Miles Capital invested in 0.27% or 5,253 shares. Fdx, California-based fund reported 117,177 shares. Alpine Woods Cap Ltd Llc holds 0.17% of its portfolio in The Procter & Gamble Company (NYSE:PG) for 36,336 shares. Retirement Planning Gp has invested 0.1% in The Procter & Gamble Company (NYSE:PG). Peapack Gladstone Fincl reported 206,059 shares or 1.08% of all its holdings.

Girard Partners Ltd, which manages about $604.19M and $484.32 million US Long portfolio, upped its stake in Priceline Grp Inc (NASDAQ:PCLN) by 300 shares to 1,104 shares, valued at $2.02 million in 2017Q3, according to the filing. It also increased its holding in Philip Morris Intl Inc (NYSE:PM) by 2,929 shares in the quarter, for a total of 37,926 shares, and has risen its stake in Toronto Dominion Bk Ont (NYSE:TD).

Analysts await The Procter & Gamble Company (NYSE:PG) to report earnings on January, 19. They expect $1.14 earnings per share, up 5.56% or $0.06 from last year’s $1.08 per share. PG’s profit will be $2.89 billion for 19.78 P/E if the $1.14 EPS becomes a reality. After $1.09 actual earnings per share reported by The Procter & Gamble Company for the previous quarter, Wall Street now forecasts 4.59% EPS growth.

Since August 15, 2017, it had 0 buys, and 19 selling transactions for $6.75 million activity. Shares for $339,077 were sold by Pritchard Marc S.. 2,660 The Procter & Gamble Company (NYSE:PG) shares with value of $244,828 were sold by Biegger Mark F. The insider Taylor David S sold $587,402. 6,063 The Procter & Gamble Company (NYSE:PG) shares with value of $558,042 were sold by Moeller Jon R. $144,688 worth of The Procter & Gamble Company (NYSE:PG) was sold by Fish Kathleen B. Majoras Deborah P sold $231,206 worth of stock.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts